The most comprehensive forum on the science behind cannabis, its potential therapeutic benefits and the societal and health impacts of legalization of non-medical cannabis from leading researchers and physicians in the field.
Attend the Conference In-Person or Virtually!
The 2023 Cannabinoids in Clinical Practice Conference will be a HYBRID EVENT. You can attend virtually or in-person at the Hart House in Toronto, ON. For more information, please visit the conference registration page.
What Can You Expect?
This event presents practical evidence-based education on cannabinoid therapeutics. Participants will benefit from presentations by Canadian and internationally renowned experts in a two-day hybrid event featuring updates from key researchers and stakeholders.
We’ve worked to make this conference the most comprehensive to date. Below is some of what to expect when you attend Cannabinoids in Clinical Practice 2023.
- CCIC is proud to announce that we have partnered with the Toronto Cannabis and Cannabinoid Research Consortium (TC3) to bring even greater interactive opportunities and translational learning than previous conferences, including a poster session for in-person attendees and panel discussions addressing challenges in cannabinoid therapeutics in real world situations.
- Canadian physicians and healthcare professional attendees will be updated on the evolving regulatory system and educated on the current state of knowledge regarding the health effects of cannabis and familiarized with emerging research to provide safe and effective use of cannabinoids in clinical practice.
- This event will educate health care professionals to foster accurate and evidence-based conversations with their patients on the health impacts of cannabis and will update researchers in the field on what the latest science says.
- Masking will not be mandatory, unless directed by provincial or federal policies and guidelines.
The 9th Annual Cannabinoids in Clinical Practice Conference is proudly co-hosted with the Toronto Cannabis and Cannabinoid Research Consortium (TC3)!